Elizabeth Buck

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Buck:

Company Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 170,192 $425,480 $2.50 30 Jan 2025 Direct
Black Diamond Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 250,000 21 Jan 2026 Direct

Insider Reports Filed by Elizabeth Buck

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 21 Jan 2026 1 $0 4 CHIEF SCIENTIFIC OFFICER 23 Jan 2026, 16:05
BDTX Black Diamond Therapeutics, Inc. 30 Jan 2025 2 $0 4 CHIEF SCIENTIFIC OFFICER 31 Jan 2025, 16:36
BDTX Black Diamond Therapeutics, Inc. 14 Feb 2024 1 $0 4 CHIEF SCIENTIFIC OFFICER 15 Feb 2024, 17:36
BDTX Black Diamond Therapeutics, Inc. 13 Feb 2023 1 $0 4 CHIEF SCIENTIFIC OFFICER 15 Feb 2023, 15:10
BDTX Black Diamond Therapeutics, Inc. 15 Feb 2022 1 $0 4 CHIEF SCIENTIFIC OFFICER 17 Feb 2022, 15:16
BDTX Black Diamond Therapeutics, Inc. 15 Sep 2021 0 $0 3 Chief Scientific Officer 17 Sep 2021, 16:19